New hope for advanced pancreatic cancer: combo therapy with or without radiation enters trial
NCT ID NCT06662006
First seen Feb 06, 2026 · Last updated May 13, 2026 · Updated 12 times
Summary
This study tests a second-line treatment for people with advanced pancreatic cancer that has spread and no longer responds to initial chemotherapy. Participants receive a combination of chemotherapy (nal-IRI/5-FU/LV), an immunotherapy (PD-L1 inhibitor), and a targeted anti-angiogenic drug, with or without focused radiation (SBRT). The goal is to see if this approach can shrink or control tumors. The trial plans to enroll 56 adults aged 18–75.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED METASTATIC PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
RECRUITINGNanjing, Jiangsu, 025, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.